Abstract
Objective
The aim of this study was to describe the relationship between sociodemographic characteristics and human immunodeficiency (HIV) status of a cohort of injection drug users (IDUs) on their self-reported health service utilization.
Design
Interviewer-administered questionnaire.
Methods
IDUs who had injected illicit drugs within the previous month were recruited through street outreach. They underwent serology for HIV-1 and questionnaires on demographics, drug using behaviors, housing status, and health service utilization (hospitalization overnight and emergency department visits) in the previous 6 months. Logistic regression analysis was used to identify independent associations with the use of health services.
Results
Of 1,103 cohort participants, 65% were male, 63% were white, and 23% were HIV positive. Cocaine was the most frequently injected drug used. Almost half (47%) had used health services in the previous 6 months. The following variables were associated independently with health service utilization (adjusted odds ratio; 95% confidence interval): unstable housing, defined as living primarily in a hotel, boarding room, or transition house or on the street in the past 6 months (1.44; 1.11–1.86); female gender (1.45; 1.11–1.89); HIV-positive status (1.43; 1.06–1.92); injection of cocaine (1.50; 1.12–2.02); and primary care physician visit in past 6 months (1.91; 1.39–2.64).
Conclusion
IDUs with unstable housing were more likely to report emergency department and hospital use, which may be a reflection of their disorganized lifestyle or poorer health status. Further studies are required to assess the effect on the health status and health care use of IDUs of interventions that increase the availability of safe, affordable housing.
Key Words: Canada, Drug Users, Health Services Utilization, Hospitalization, Housing
Full Text
The Full Text of this article is available as a PDF (517.1 KB).
Footnotes
Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital
References
- 1.Alcabes P, Friedland G. Injection drug use and human immunodeficiency virus infection. Clin Infect Dis. 1995;20:1467–1479. doi: 10.1093/clinids/20.6.1467. [DOI] [PubMed] [Google Scholar]
- 2.Strathdee SA, Ameijden EJC, Mesquita F, Wodak A, Rana S, Vlahov DZ. Can HIV epidemics among injection drug users be prevented? AIDS. 1998;12(suppl A):S71–S79. [PubMed] [Google Scholar]
- 3.Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59–F65. doi: 10.1097/00002030-199708000-00001. [DOI] [PubMed] [Google Scholar]
- 4.Jarlais DC. Comments of Stimson's “Has the United Kingdom averted an epidemic of HIV-1 infection among drug users?”. Addiction. 1996;91:1089–1090. doi: 10.1046/j.1360-0443.1996.91810892.x. [DOI] [PubMed] [Google Scholar]
- 5.Eskild A, Magnus P, Samuelsen SO, Sohlberg C, Kittelsen P. Differences in mortality rates and causes of death between HIV positive and HIV negative intravenous drug users. Int J Epidemiol. 1993;22:315–321. doi: 10.1093/ije/22.2.315. [DOI] [PubMed] [Google Scholar]
- 6.Haastrecht JAR, Ameijden EJC, Hoek JAR, Mientes GHC, Bax JS, Coutinho RA. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am J Epidemiol. 1996;143:380–391. doi: 10.1093/oxfordjournals.aje.a008752. [DOI] [PubMed] [Google Scholar]
- 7.Rietmejeer CA, Davidson AJ, Foster CT, Cohn DL. Cost of care for patients with human immunodeficiency virus: patterns of utilization and charges in a public health care system. Arch Intern Med. 1993;153:219–225. [PubMed] [Google Scholar]
- 8.Mor V, Fleishman JA, Dresser M, Piette J. Variation in health service use among HIV-infected patients. Med Care. 1992;30:17–29. doi: 10.1097/00005650-199201000-00002. [DOI] [PubMed] [Google Scholar]
- 9.Therapeutic Guidelines for the Treatment of HIV/AIDS and Related Conditions. Vancouver, BC: St. Paul's Hospital; 1996. [Google Scholar]
- 10.Patrick DM, Strathdee SA, Archibald CP, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS. 1997;8:437–445. doi: 10.1258/0956462971920497. [DOI] [PubMed] [Google Scholar]
- 11.Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioural settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:273–280. doi: 10.1097/00042560-199611010-00010. [DOI] [PubMed] [Google Scholar]
- 12.Friedman SR, Jose B, Deren S, Jarlais DC, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol. 1995;142:864–874. doi: 10.1093/oxfordjournals.aje.a117726. [DOI] [PubMed] [Google Scholar]
- 13.Gostin LO, Lazzarini Z, Jones TS, Flaherty K. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. JAMA. 1997;277:53–64. [PubMed] [Google Scholar]
- 14.Hartgers C, Ameijden EF, Hoek JA, Coutinho RA. Needle sharing and participating in the Amsterdam syringe exchange programme among HIV-seronegative injecting drug users. Public Health Rep. 1992;102:675–681. [PMC free article] [PubMed] [Google Scholar]
- 15.Reyes JC, Robles RR, Colon HM, Freeman DH, Sahai H, Matos TD. Risk factors for shooting gallery use among drug injectors in Puerto Rico. P R Health Sci J. 1996;15:227–231. [PubMed] [Google Scholar]
- 16.Salit SA, Kuhn EM, Hartz AJ, Vu JM, Mosso AL. Hospitalization costs associated with homelessness in New York City. N Engl J Med. 1998;338:1734–1740. doi: 10.1056/NEJM199806113382406. [DOI] [PubMed] [Google Scholar]
- 17.Hellinger F. The use of health services by women with HIV infection. Health Serv Res. 1993;28:543–561. [PMC free article] [PubMed] [Google Scholar]
- 18.Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health. 1991;81:1285–1290. doi: 10.2105/ajph.81.10.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Solomon L, Stein M, Flynn C, et al. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS) J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:253–261. doi: 10.1097/00042560-199803010-00011. [DOI] [PubMed] [Google Scholar]
- 20.Graham NMH, Jacobson LP, Kuo V, Chmiel JS, Morgenstern H, Zucconi S. Access to therapy in the multicenter AIDS cohort study, 1989–1992. J Clin Epidemiol. 1994;47:1003–1012. doi: 10.1016/0895-4356(94)90115-5. [DOI] [PubMed] [Google Scholar]
- 21.Spijkerman IJ, Ameijden EJ, Mientjes GH, Coutinho RA, Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49:1149–1157. doi: 10.1016/0895-4356(96)00180-1. [DOI] [PubMed] [Google Scholar]
- 22.Mientjes GH, Spijkerman IJ, Ameijden EJ, Hoek A, Coutinho RA. Incidence and risk factors for pneumonia in HIV infected and non-infected drug users. J Infect. 1996;32:181–186. doi: 10.1016/S0163-4453(96)80017-X. [DOI] [PubMed] [Google Scholar]
- 23.Hudgins R, McCusker J, Stoddard A. Cocaine use and risky injection and sexual behaviours. Drug Alcohol Depend. 1995;37:7–14. doi: 10.1016/0376-8716(94)01060-x. [DOI] [PubMed] [Google Scholar]